Modulation of protein kinase signaling cascades by palytoxin

Toxicon

Volumn 57, Issue 3, 2011, Pages 440-448

  Wattenberg, Elizabeth V ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Dual specificity phosphatase; Mitogen activated protein kinase; Na+, K+ ATPase; Palytoxin; Tumor promoter

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DUAL SPECIFICITY PHOSPHATASE 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; PALYTOXIN; PROTEIN SERINE THREONINE KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; AUTOCRINE EFFECT; CARCINOGENESIS; CARCINOGENICITY; CELL FATE; CELL FUNCTION; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; ION CURRENT; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACRYLAMIDES; CALCIUM; CARCINOGENS; CELL NUCLEUS; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; SIGNAL TRANSDUCTION;

EID: 79952317589     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.11.003     Document Type: Article

References (91)

1. Abe J., Kusuhara M., Ulevitch R.J., Berk B.C., Lee J.D. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J. Biol. Chem. 1996, 271:16586-16590.
2. Albanell J., Codony-Servat J., Rojo F., Del Campo J.M., Sauleda S., Anido J., Raspall G., Giralt J., Rosello J., Nicholson R.I., Mendelsohn J., Baselga J. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res. 2001, 61:6500-6510.
3. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1991, 1072:129-157.
4. Balmain A., Pragnell I.B. Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 1983, 303:72-74.
5. Bloethner S., Chen B., Hemminki K., Muller-Berghaus J., Ugurel S., Schadendorf D., Kumar R. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines. Carcinogenesis 2005, 26:1224-1232.
6. Bonnard C., Lechner J.F., Gerwin B.I., Fujiki H., Harris C.C. Effects of palytoxin or ouabain on growth and squamous differentiation of human bronchial epithelial cells in vitro. Carcinogenesis 1988, 9:2245-2249.
7. Bourcier C., Jacquel A., Hess J., Peyrottes I., Angel P., Hofman P., Auberger P., Pouyssegur J., Pages G. p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis. Cancer Res. 2006, 66:2700-2707.
8. Camps M., Nichols A., Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. Faseb J. 2000, 14:6-16.
9. Chao T.H., Hayashi M., Tapping R.I., Kato Y., Lee J.D. MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. J. Biol. Chem. 1999, 274:36035-36038.
10. Charlson A.T., Zeliadt N.A., Wattenberg E.V. Extracellular signal regulated kinase 5 mediates signals triggered by the novel tumor promoter palytoxin. Toxicol. Appl. Pharmacol. 2009, 241:143-153.
11. Chen Z., Gibson T.B., Robinson F., Silvestro L., Pearson G., Xu B., Wright A., Vanderbilt C., Cobb M.H. MAP kinases. Chem. Rev. 2001, 101:2449-2476.
12. Cohen C., Zavala-Pompa A., Sequeira J.H., Shoji M., Sexton D.G., Cotsonis G., Cerimele F., Govindarajan B., Macaron N., Arbiser J.L. Mitogen-actived protein kinase activation is an early event in melanoma progression. Clin. Cancer Res. 2002, 8:3728-3733.
13. Croonquist P.A., Linden M.A., Zhao F., Van Ness B.G. Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells. Blood 2003, 102:2581-2592.
14. Cuevas B.D., Abell A.N., Johnson G.L. Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene 2007, 26:3159-3171.
15. Davis R.J. MAPKs: new JNK expands the group. Trends Biochem. Sci. 1994, 19:470-473.
16. Derijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., Davis R.J. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 1995, 267:682-685.
17. Dhillon A.S., Hagan S., Rath O., Kolch W. MAP kinase signalling pathways in cancer. Oncogene 2007, 26:3279-3290.
18. Dinev D., Jordan B.W., Neufeld B., Lee J.D., Lindemann D., Rapp U.R., Ludwig S. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep. 2001, 2:829-834.
19. Engelberg D. Stress-activated protein kinases-tumor suppressors or tumor initiators?. Semin. Cancer Biol. 2004, 14:271-282.
20. Farooq A., Zhou M.M. Structure and regulation of MAPK phosphatases. Cell Signal. 2004, 16:769-779.
21. Friedman B., Frackelton A.R., Ross A.H., Connors J.M., Fujiki H., Sugimura T., Rosner M.R. Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:3034-3038.
22. Fujiki H., Suganuma M., Tahira T., Yoshioka A., Nakayasu M., Endo Y., Shudo K., Takayama S., Moore R.E., Sugimura T. Nakahara memorial lecture. New classes of tumor promoters: teleocidin, aplysiatoxin, and palytoxin. Princess Takamatsu Symp. 1983, 14:37-45.
23. Fujiki H., Suganuma M., Nakayasu M., Hakii H., Horiuchi T., Takayama S., Sugimura T. Palytoxin is a non-12-O-tetradecanoylphorbol-13-acetate type tumor promoter in two-stage mouse skin carcinogenesis. Carcinogenesis 1986, 7:707-710.
24. Furukawa T., Sunamura M., Motoi F., Matsuno S., Horii A. Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am. J. Pathol. 2003, 162:1807-1815.
25. Gille H., Strahl T., Shaw P.E. Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr. Biol. 1995, 5:1191-1200.
26. Griner E.M., Kazanietz M.G. Protein kinase C and other diacylglycerol effectors in cancer. Nat. Rev. Cancer 2007, 7:281-294.
27. Habermann E. Palytoxin acts through Na+, K+-ATPase. Toxicon 1989, 27:1171-1187.
28. Han J., Lee J.D., Jiang Y., Li Z., Feng L., Ulevitch R.J. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J. Biol. Chem. 1996, 271:2886-2891.
29. Hayashi M., Lee J.D. Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice. J. Mol. Med. 2004, 82:800-808.
30. Hennings H., Glick A.B., Greenhalgh D.A., Morgan D.L., Strickland J.E., Tennenbaum T., Yuspa S.H. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis. Proc. Soc. Exp. Biol. Med. 1993, 202:1-8.
31. Hoshino R., Chatani Y., Yamori T., Tsuruo T., Oka H., Yoshida O., Shimada Y., Ari-i S., Wada H., Fujimoto J., Kohno M. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 1999, 18:813-822.
32. Iordanov M.S., Magun B.E. Loss of cellular K+ mimics ribotoxic stress. Inhibition of protein synthesis and activation of the stress kinases SEK1/MKK4, stress-activated protein kinase/c-Jun NH2-terminal kinase 1, and p38/HOG1 by palytoxin. J. Biol. Chem. 1998, 273:3528-3534.
33. Kamakura S., Moriguchi T., Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J. Biol. Chem. 1999, 274:26563-26571.
34. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 1997, 9:240-246.
35. Kato Y., Kravchenko V.V., Tapping R., Han J., Ulevitch R.J., Lee J.D. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 1997, 16:7054-7066.
36. Kato Y., Tapping R.I., Huang S., Watson M.H., Ulevitch R.J., Lee J.D. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 1998, 395:713-716.
37. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 2000, 12:186-192.
38. Keyse S.M. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 2008, 27:253-261.
39. Kim S.C., Hahn J.S., Min Y.H., Yoo N.C., Ko Y.W., Lee W.J. Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1. Blood 1999, 93:3893-3899.
40. Kuroki D.W., Bignami G.S., Wattenberg E.V. Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin. Cancer Res. 1996, 56:637-644.
41. Kuroki D.W., Minden A., Sanchez I., Wattenberg E.V. Regulation of a c-Jun amino-terminal kinase/stress-activated protein kinase cascade by a sodium-dependent signal transduction pathway. J. Biol. Chem. 1997, 272:23905-23911.
42. Lee J.D., Ulevitch R.J., Han J. Primary structure of BMK1: a new mammalian map kinase. Biochem. Biophys. Res. Commun. 1995, 213:715-724.
43. Li S., Wattenberg E.V. Differential activation of mitogen-activated protein kinases by palytoxin and ouabain, two ligands for the Na+, K+-ATPase. Toxicol. Appl. Pharmacol. 1998, 151:377-384.
44. Li S., Wattenberg E.V. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin. Toxicol. Appl. Pharmacol. 1999, 160:109-119.
45. Lin A., Minden A., Martinetto H., Claret F.X., Lange-Carter C., Mercurio F., Johnson G.L., Karin M. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 1995, 268:286-290.
46. Marchetti S., Gimond C., Roux D., Gothie E., Pouyssegur J., Pages G. Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice. J. Cell Physiol. 2004, 199:441-450.
47. Marchetti S., Gimond C., Chambard J.C., Touboul T., Roux D., Pouyssegur J., Pages G. Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation. Mol. Cell. Biol. 2005, 25:854-864.
48. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995, 80:179-185.
49. McCawley L.J., Li S., Wattenberg E.V., Hudson L.G. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J. Biol. Chem. 1999, 274:4347-4353.
50. Miura D., Kobayashi M., Kakiuchi S., Kasahara Y., Kondo S. Enhancement of transformed foci and induction of prostaglandins in Balb/c 3T3 cells by palytoxin: in vitro model reproduces carcinogenic responses in animal models regarding the inhibitory effect of indomethacin and reversal of indomethacin's effect by exogenous prostaglandins. Toxicol. Sci. 2006, 89:154-163.
51. Mody N., Campbell D.G., Morrice N., Peggie M., Cohen P. An analysis of the phosphorylation and activation of extracellular-signal-regulated protein kinase 5 (ERK5) by mitogen-activated protein kinase kinase 5 (MKK5) in vitro. Biochem. J. 2003, 372:567-575.
52. Moriguchi T., Toyoshima F., Gotoh Y., Iwamatsu A., Irie K., Mori E., Kuroyanagi N., Hagiwara M., Matsumoto K., Nishida E. Purification and identification of a major activator for p38 from osmotically shocked cells. Activation of mitogen-activated protein kinase kinase 6 by osmotic shock, tumor necrosis factor-alpha, and H2O2. J. Biol. Chem. 1996, 271:26981-26988.
53. Muda M., Boschert U., Dickinson R., Martinou J.C., Martinou I., Camps M., Schlegel W., Arkinstall S. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 1996, 271:4319-4326.
54. Murphy L.O., Smith S., Chen R., Fingar D.C., Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 2002, 4:556-564.
55. Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 1984, 308:693-698.
56. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 1996, 16:1247-1255.
57. Raman M., Chen W., Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 2007, 26:3100-3112.
58. Roux P.P., Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 2004, 68:320-344.
59. Sala G.L., Bellocci M., Rossini G.P. The cytotoxic pathway triggered by palytoxin involves a change in the cellular pool of stress response proteins. Chem. Res. Toxicol. 2009, 22:2009-2016.
60. Sanchez I., Hughes R.T., Mayer B.J., Yee K., Woodgett J.R., Avruch J., Kyriakis J.M., Zon L.I. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 1994, 372:794-798.
61. Santen R.J., Song R.X., McPherson R., Kumar R., Adam L., Jeng M.H., Yue W. The role of mitogen-activated protein (MAP) kinase in breast cancer. J. Steroid Biochem. Mol. Biol. 2002, 80:239-256.
62. Sasaki T., Kojima H., Kishimoto R., Ikeda A., Kunimoto H., Nakajima K. Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role. Mol. Cell 2006, 24:63-75.
63. Segrelles C., Ruiz S., Perez P., Murga C., Santos M., Budunova I.V., Martinez J., Larcher F., Slaga T.J., Gutkind J.S., Jorcano J.L., Paramio J.M. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene 2002, 21:53-64.
64. Smalley K.S. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?. Int. J. Cancer 2003, 104:527-532.
65. Sohn S.J., Lewis G.M., Winoto A. Non-redundant function of the MEK5-ERK5 pathway in thymocyte apoptosis. EMBO J. 2008, 27:1896-1906.
66. Stein B., Brady H., Yang M.X., Young D.B., Barbosa M.S. Cloning and characterization of MEK6, a novel member of the mitogen-activated protein kinase kinase cascade. J. Biol. Chem. 1996, 271:11427-11433.
67. Stokoe D., Engel K., Campbell D.G., Cohen P., Gaestel M. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett. 1992, 313:307-313.
68. Strickland J.E., Greenhalgh D.A., Koceva-Chyla A., Hennings H., Restrepo C., Balaschak M., Yuspa S.H. Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res. 1988, 48:165-169.
69. Sun W., Kesavan K., Schaefer B.C., Garrington T.P., Ware M., Johnson N.L., Gelfand E.W., Johnson G.L. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. J. Biol. Chem. 2001, 276:5093-5100.
70. Terasawa K., Okazaki K., Nishida E. Regulation of c-Fos and Fra-1 by the MEK5-ERK5 pathway. Genes Cells 2003, 8:263-273.
71. Turjanski A.G., Vaque J.P., Gutkind J.S. MAP kinases and the control of nuclear events. Oncogene 2007, 26:3240-3253.
72. Vale C., Gomez-Limia B., Vieytes M.R., Botana L.M. Mitogen-activated protein kinases regulate palytoxin-induced calcium influx and cytotoxicity in cultured neurons. Br. J. Pharmacol. 2007, 152:256-266.
73. Wang X., Tournier C. Regulation of cellular functions by the ERK5 signalling pathway. Cell. Signal. 2006, 18:753-760.
74. Warmka J.K., Winston S.E., Zeliadt N.A., Wattenberg E.V. Extracellular signal-regulated kinase transmits palytoxin-stimulated signals leading to altered gene expression in mouse keratinocytes. Toxicol. Appl. Pharmacol. 2002, 185:8-17.
75. Warmka J.K., Mauro L.J., Wattenberg E.V. Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras. J. Biol. Chem. 2004, 279:33085-33092.
76. Wattenberg E.V., Fujiki H., Rosner M.R. Heterologous regulation of the epidermal growth factor receptor by palytoxin, a non-12-O-tetradecanoylphorbol-13-acetate-type tumor promoter. Cancer Res. 1987, 47:4618-4622.
77. Wattenberg E.V., Byron K.L., Villereal M.L., Fujiki H., Rosner M.R. Sodium as a mediator of non-phorbol tumor promoter action. Down-modulation of the epidermal growth factor receptor by palytoxin. J. Biol. Chem. 1989, 264:14668-14673.
78. Wattenberg E.V., McNeil P.L., Fujiki H., Rosner M.R. Palytoxin down-modulates the epidermal growth factor receptor through a sodium-dependent pathway. J. Biol. Chem. 1989, 264:213-219.
79. Wattenberg E.V., Uemura D., Byron K.L., Villereal M.L., Fujiki H., Rosner M.R. Structure-activity studies of the nonphorbol tumor promoter palytoxin in Swiss 3T3 cells. Cancer Res. 1989, 49:5837-5842.
80. Wattenberg E.V. Palytoxin: exploiting a novel skin tumor promoter to explore signal transduction and carcinogenesis. Am. J. Physiol. Cell Physiol. 2007, 292:C24-C32.
81. Whitmarsh A.J., Davis R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 1996, 74:589-607.
82. Whitmarsh A.J., Shore P., Sharrocks A.D., Davis R.J. Integration of MAP kinase signal transduction pathways at the serum response element. Science 1995, 269:403-407.
83. Xie Z., Cai T. Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol. Interv. 2003, 3:157-168.
84. Xie Z. Molecular mechanisms of Na/K-ATPase-mediated signal transduction. Ann. N. Y. Acad. Sci. 2003, 986:497-503.
85. Yip-Schneider M.T., Lin A., Marshall M.S. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2. Biochem. Biophys. Res.Commun. 2001, 280:992-997.
86. Young M.R., Li J.J., Rincon M., Flavell R.A., Sathyanarayana B.K., Hunziker R., Colburn N. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:9827-9832.
87. Yuspa S.H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J. Dermatol. Sci. 1998, 17:1-7.
88. Zeliadt N.A., Warmka J.K., Wattenberg E.V. Mitogen activated protein kinases selectively regulate palytoxin-stimulated gene expression in mouse keratinocytes. Toxicol. Appl. Pharmacol. 2003, 192:212-221.
89. Zeliadt N.A., Warmka J.K., Winston S.E., Kahler R., Westendorf J.J., Mauro L.J., Wattenberg E.V. Tumor promoter-induced MMP-13 gene expression in a model of initiated epidermis. Biochem. Biophys. Res. Commun. 2004, 317:570-577.
90. Zeliadt N.A., Mauro L.J., Wattenberg E.V. Reciprocal regulation of extracellular signal regulated kinase 1/2 and mitogen activated protein kinase phosphatase-3. Toxicol. Appl. Pharmacol. 2008, 232:408-417.
91. Zhou G., Bao Z., Dixon J.E. Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 1995, 270:12665-12669.